1887
Volume 2023, Issue 2
  • EISSN:

Abstract

This research aimed to assess coronavirus disease 2019 (COVID-19) vaccine administration errors at Primary Health Care Centres (PHCC) in Qatar and provide corrective measures to enhance patient safety based on the Centre for Communicable Diseases recommendations.

A retrospective analysis was conducted on the electronic medical records of patients receiving COVID-19 vaccines at PHCC between 23 December 2020 and 31 December 2021. Demographic information, vaccine details, administration dates, lot numbers, and vaccination sites were extracted. A descriptive analysis was performed to calculate the percentages of common vaccine administration errors outlined by the CDC.

PHCC administered 2,797,941 and 694,643 vaccine doses in 2021 and 2022, respectively. The primary error category was data quality, with the highest observed error being a discrepancy between vaccine expiration dates and actual dates (3.1% in December 2022). In 2021, all error percentages within data quality were below 0.37%. Notably, the most prevalent vaccine administration deviation in 2021 was interval rule 2, where the second dose was administered more than 42 days after the first dose. The highest deviation (1.59%) was reported in November.

Vaccination remains crucial for disease prevention, necessitating accurate vaccine administration processes. The study underscores the importance of effective implementation and monitoring of vaccination programmes. PHCC’s strategies, including ongoing training, adherence to guidelines, and a monitoring dashboard, contributed to better error understanding. This approach facilitated targeted training and communication efforts to enhance patient safety and minimise potential harm. The findings highlight the significance of continuous improvement in vaccine administration to ensure the success of public health interventions.

Loading

Article metrics loading...

/content/journals/10.5339/qjph.2023.6
2023-11-20
2024-07-18
Loading full text...

Full text loading...

/deliver/fulltext/qjph/2023/2/qjph.2023.6.html?itemId=/content/journals/10.5339/qjph.2023.6&mimeType=html&fmt=ahah

References

  1. WHO ., WHO coronavirus (COVID-19) dashboard. Geneva: World Health Organization, 2019. https://covid19.who.int/ (accessed Apr 28, 2023).
    [Google Scholar]
  2. Moghadas, S.. et al.., The impact of vaccination on COVID-19 outbreaks in the United States. Clinical Infectious Diseases, 2021. 73:(12): pp. 2257-2264. https://doi.org/10.1093/cid/ciab079
    [Google Scholar]
  3. WHO ., Evaluation of COVID-19 vaccine effectiveness. Geneva: World Health Organization, 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1 (accessed Nov 16, 2021)
    [Google Scholar]
  4. Draft landscape and tracker of COVID-19 candidate vaccines. Geneva: World Health Organization, 2021 https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines/ (accessed Nov 15, 2021)
    [Google Scholar]
  5. Beaumont, P., Covid-19 vaccine: Who are countries prioritizing for first doses? The Guardian. 18 November 2020 https://www.theguardian.com/world/2020/nov/18/covid-19-vaccine-who-are-countries-prioritising-for-first-doses/ (accessed Nov 15, 2021)
    [Google Scholar]
  6. Polack, F.P., et al.., Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New England Journal of Medicine, 2020. 383: :pp. 2603-2615.
    [Google Scholar]
  7. Baden, L.R., et al.., Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine, 2021. 384:(5): pp. 403-416.
    [Google Scholar]
  8. US Food and Drug Administration ., Vaccines and related biological products. Advisory Committee meeting: FDA briefing document. https://www.fda.gov/advisory-committees/advisory-committee-calendar-vaccines-and-related-biological-products-advisory-committee-february26-2021-meeting-announcement (accessed Nov 18, 2021)
    [Google Scholar]
  9. Voysey, M., et al.., Safety and efficacy of the ChAdOx1 CoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK. Lancet, 2021. 397:(10269): pp. 99-111.
    [Google Scholar]
  10. Qatar’s Ministry of Public Health (MOPH) . COVID-19 Vaccine. 2021. Retrieved from: https://covid19.moph.gov.qa/EN/Covid19-Vaccine/Pages/default.aspx (accessed Nov 18, 2021)
    [Google Scholar]
  11. Al-Kuwari, M.G., et al.., The COVID-19 pandemic impact on primary health care services: An experience from Qatar. World Family Medicine, 2021. 19:(4): pp. 105-110. doi: 10.5742/MEWFM.2021.94033.
    [Google Scholar]
  12. Qatar’s Ministry of Public Health (MOPH) . COVID-19 Vaccine Data. 2021. Retrieved from https://covid19.moph.gov.qa/EN/Pages/Vaccination-Program-Data.aspx (accessed Nov 22, 2021)
    [Google Scholar]
  13. Centre of Disease Control and Prevention . COVID-19 vaccine administration errors and deviations. Jun 2021. Retrieved from: https://www.cdc.gov/vaccines/covid-19/downloads/covid19-vaccine-errors-deviations.pdf (accessed Nov 15, 2021)
    [Google Scholar]
  14. Ehsani-Moghaddam, B., Martin, K., Queenan J.A., Data quality in healthcare: A report of practical experience with the Canadian Primary Care Sentinel Surveillance Network data. Health Information Management, 2021. 50:(1-2): pp. 88-92. doi: 10.1177/1833358319887743.
    [Google Scholar]
  15. Kim, H., et al.., Impact of vaccination and the omicron variant on COVID-19 severity in pregnant women. American Journal of Infection Control, 2023. 51:(3): pp. 351-353. Epub ahead of print.
    [Google Scholar]
  16. Stepanova, M., et al.., The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19. BMC Infectious Diseases, 2022. 22:: p. 702.
    [Google Scholar]
  17. Thielmann, A., Viehmann, A., Weltermann B.M., Effectiveness of a web-based education program to improve vaccine storage conditions in primary care (Keep Cool): Study protocol for a randomized controlled trial. Trials, 2015. 16:: p. 301.
    [Google Scholar]
  18. Hampton, L.M., Vaccine handling and administration errors should be addressed to improve vaccine program safety. Vaccine, 2020. 38:(32):pp. 4933-4934.
    [Google Scholar]
  19. Harnden, A., Lim, W.S., Earnshaw A. , COVID-19 vaccination programme: A central role for primary care. British Journal of General Practice, 2021. 71:(703): pp. 52-53.
    [Google Scholar]
  20. World Health Organization, United Nations Children’s Fund . Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines: Interim guidance, 16 November 2020. Geneva: World Health Organization; 2020. Available from: https://apps.who.int/iris/handle/10665/336603 (accessed Mar 14, 2023).
    [Google Scholar]
  21. Al Kuwari, M.G., et al.., The impact of COVID-19 on primary health care services in Qatar: 2 years of response and coping 2020-2021. Journal of Family Medicine and Primary Care, 2022. 11:(12): pp. 7743-7749. doi: 10.4103/jfmpc.jfmpc_1259_22.
    [Google Scholar]
  22. Al-Kuwari, M.G., et al.., Epidemiological health assessment in primary healthcare in Qatar-2019. Qatar Medical Journal, 2021. 2021 (3):: p. 57.
    [Google Scholar]
  23. Ministry of Public Health . Coronavirus Disease 2019 (COVID-19) Updates Qatar, 2022. Available from: https://covid19.moph.gov.qa/EN/Pages/Vaccination-Program-Data.aspx (accessed Jun 14, 2022).
    [Google Scholar]
  24. Hall, E., et al.., Qualitative conceptual content analysis of COVID-19 vaccine administration error inquiries. Vaccines (Basel), 2023. 11:(2): p. 254. doi: 10.3390/vaccines11020254.
    [Google Scholar]
  25. CDC . Storage and handling. Available online: https://www2.cdc.gov/vaccines/ed/covid19/SHVA/20010.asp (accessed in March 2023).
    [Google Scholar]
  26. CDC . Moderna COVID-19 vaccine, storage and handling summary. CDC: Atlanta, GA, USA, 2022.
    [Google Scholar]
  27. Centres of Disease Control and Prevention . Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. Available online: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#Interchangeability (accessed on May 1, 2023).
    [Google Scholar]
  28. Institute for Safe Medication Practices (ISMP) . Any new process poses a risk for errors: Learning from 4 months of coronavirus disease 2019 (COVID-19) vaccinations. Available online: https://www.ismp.org/resources/any-new-process-poses-risk-errorslearning- 4-months-coronavirus-disease-2019-covid-19 (accessed on April 5, 2023).
    [Google Scholar]
  29. Chiodini, J., Vaccine storage: A hot topic for cool practice. Travel Medicine and Infectious Disease, 2019. 31:: p. 101477.
    [Google Scholar]
  30. Thielmann, A., Puth, M.T., WeltermannB., Improving knowledge on vaccine storage management in general practices: Learning effectiveness of an online-based program. Vaccine, 2020. 38:: pp. 7551-7557.
    [Google Scholar]
  31. Reed, L., Tarini, B.A., Andreae M.C., Vaccine administration error rates at a large academic medical centre and its affiliated clinics-Familiarity matters. Vaccine, 2019. 37:: pp. 5390-5396.
    [Google Scholar]
  32. Lang, S., et al.., Immunisation errors reported to a vaccine advice service: Intelligence to improve practice. Quality in Primary Care, 2014. 22:: pp. 139-146.
    [Google Scholar]
  33. Hibbs, B.F., Miller, E.R., Shimabukuro T., Notes from the field: Rotavirus vaccine administration errors-United States, 2006-2013. Morbidity and Mortality Weekly Report, 2014. 63:(04): p. 81.
    [Google Scholar]
  34. CDC . Vaccine administration: Preventing vaccine administration errors. Available online: https://www.cdc.gov/vaccines/hcp/admin/downloads/vaccine-administration-preventing-errors.pdf (accessed on April 4, 2023).
    [Google Scholar]
  35. Paparella, S.F., Vaccine errors: Understanding the risks and the responsibilities for public safety. Journal of Emergency Nursing, 2015. 41:(5): pp. 428-430.
    [Google Scholar]
/content/journals/10.5339/qjph.2023.6
Loading
/content/journals/10.5339/qjph.2023.6
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): COVID-19errors and deviationspharmacyQatar and vaccination
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error